Namita Thapar’s Emcure Pharma Soars 38,200% on NSE Debut

As Emcure Pharma debuted on the NSE with a 31% premium, well-known investor from Shark Tank India and Emcure Pharmaceuticals executive director Namita Thapar is witnessing incredible returns on her money. Originally ₹2.19 crore, Thapar’s initial investment in the company has now risen to almost ₹671 crore following the IPO. Starting on the NSE at…

Read More

The Global Pulse: Navigating Domestic Stocks Amid Worldwide Shifts

Domestic stock markets are no longer independent entities in the connected world of today. Global market dynamics, significant geopolitical events, and changes in currency exchange rates all have a significant impact on them. For investors, this complex web of variables provides a challenging environment that requires a deep comprehension of global forces to successfully navigate….

Read More